Prof. Hong Xiang | Diseases | Best Researcher Award

Prof. Hong Xiang | Diseases | Best Researcher Award

Associate Researcher, First Affiliated Hospital of Dalian Medical University, China

Dr. Hong Xiang is an accomplished researcher specializing in integrated medicine intervention for exocrine pancreatic diseases. With a strong track record of pioneering multi-omics platforms and 3D pancreatic organoid co-culture technologies, Dr. Xiang has contributed significantly to discovering new therapeutic targets and developing innovative peptide drugs and mRNA vaccines. He is a recognized member of several prestigious scientific societies, actively advancing pancreatic disease research.

Publication Profile

Scopus

ORCID

Education Background 🎓

Dr. Xiang holds advanced degrees in biomedical sciences and has undergone extensive training in multi-omics platforms and organoid technology, which form the foundation of his cutting-edge research in pancreatic diseases.

Professional Experience 💼

Currently engaged in cutting-edge research, Dr. Xiang has published 24 journal articles in top-tier SCI and Scopus-indexed journals, authored multiple patents (13), and contributed to several books. He holds memberships in notable professional bodies such as the American Pancreatic Association and Chinese Society of Inventions, reflecting his leadership in translational medicine and drug development.

Awards and Honors 🏆

Among his accolades, Dr. Xiang received the Dalian Science and Technology Talent Innovation Support Program Project award for Outstanding Young Science and Technology Talents (2022RY16). His innovative work in integrated medicine and pancreatic disease treatment continues to earn him recognition in academic and scientific communities.

Research Focus 🔬

Dr. Xiang’s primary research focus lies in integrated medicine for exocrine pancreatic diseases, with key discoveries targeting S100A9, RFTN1, and HTRA1 proteins implicated in pancreatitis and cancer transformation. His development of attenuated peptide drugs and mRNA vaccines highlights a promising therapeutic frontier in pancreatic oncology and inflammation.

Conclusion ✨

Dr. Hong Xiang exemplifies a leading figure in pancreatic disease research, merging innovative technology platforms with translational medicine. His contributions pave the way for novel therapies that can revolutionize treatment paradigms, securing his status as a deserving candidate for the Best Researcher Award.

Publication Top Notes 📚

  1. Prospect of Gold Nanoparticles in Pancreatic Cancer
    Pharmaceutics, 2024 | DOI:10.3390/pharmaceutics16060806
    Co-authors: Tianyi Yin, Jingrun Han, Yuying Cui, Dong Shang, Hong Xiang

  2. Vanin1 (VNN1) in chronic diseases: Future directions for targeted therapy
    European Journal of Pharmacology, 2024 | DOI:10.1016/j.ejphar.2023.176220
    Co-authors: Hao Yu, Yuying Cui, Fangyue Guo, YuTong Zhu, Xiaonan Zhang, Dong Shang, Deshi Dong, Hong Xiang

  3. Carfilzomib relieves pancreatitis-initiated pancreatic ductal adenocarcinoma by inhibiting high-temperature requirement protein A1
    Cell Death Discovery, 2024 | DOI:10.1038/s41420-024-01806-w
    Co-authors: Fangyue Guo, Xufeng Tao, Yu Wu, Deshi Dong, Yanna Zhu, Dong Shang, Hong Xiang

  4. Tryptophan metabolite norharman secreted by cultivated Lactobacillus attenuates acute pancreatitis as an antagonist of histone deacetylases
    BMC Medicine, 2023 | DOI:10.1186/s12916-023-02997-2
    Co-authors: Qi Zhou, Xufeng Tao, Fangyue Guo, Yu Wu, Dawei Deng, Linlin Lv, Deshi Dong, Dong Shang, Hong Xiang

  5. Health Impacts of High BMI in China: Terrible Present and Future
    International Journal of Environmental Research and Public Health, 2022 | DOI:10.3390/ijerph192316173
    Co-authors: Hong Xiang, Runjuan Yang, Jiaxin Tu, Xi Guan, Xufeng Tao

  6. Activated Pancreatic Stellate Cells Promote Acinar Duct Metaplasia by Disrupting Mitochondrial Respiration and Releasing Reactive Oxygen Species
    Current Chinese Science, 2022 | DOI:10.2174/2210298101666210928122952
    Co-authors: Hong Xiang, Fangyue Guo, Qi Zhou, Xufeng Tao, Deshi Dong

  7. Bacterial community mapping of the intestinal tract in acute pancreatitis rats based on 16S rDNA gene sequence analysis
    RSC Advances, 2019 | DOI:10.1039/C8RA09547G
    Co-authors: Xufeng Tao, Fangyue Guo, Qi Zhou, Fenglin Hu, Hong Xiang, Gary Guishan Xiao, Dong Shang

 

Paramita Basu Mukherjee | Health Sciences | Best Researcher Award

Assoc. Prof. Dr. Paramita Basu Mukherjee | Health Sciences | Best Researcher Award

Associate Professor, New York College of Podiatric Medicine, United States

Dr. Paramita Basu is a distinguished scientist and educator specializing in infectious diseases, pharmaceutical sciences, and microbiology. Currently, she serves as an Associate Professor and Director of Infectious Diseases at the New York College of Podiatric Medicine and an Associate Professor of Pharmaceutical & Biomedical Sciences at Touro College of Pharmacy, New York. With a Ph.D. in Biological Sciences from St. John’s University, she has made significant contributions to research on biofilms, antibiotic resistance, and innovative learning methodologies. As a dedicated academic leader, she also chairs the Curriculum Committee at Touro College of Pharmacy, shaping the future of pharmaceutical education.

Publication Profile

🎓 Education

Dr. Basu earned her Ph.D. in Biological Sciences from St. John’s University, Queens, New York (2003-2008). Her research during this period focused on microbial resistance and biofilm control mechanisms, laying the foundation for her impactful work in microbiology and pharmaceutical sciences.

💼 Experience

With over a decade of experience in academia, Dr. Basu has held key positions in medical and pharmaceutical education. Since 2009, she has been an Associate Professor at Touro College of Pharmacy, where she teaches pharmaceutical and biomedical sciences. In 2022, she joined the New York College of Podiatric Medicine as the Director of Infectious Diseases, focusing on pre-clinical sciences and microbiology. Her expertise extends to curriculum development, interdisciplinary education, and research on antibiotic resistance in clinical settings.

🏆 Awards and Honors

Dr. Basu has received multiple recognitions for her outstanding research and academic contributions. She has been acknowledged for her pioneering work in antimicrobial resistance, biofilm studies, and the integration of audiovisual learning in medical education. Her research has been published in top-tier scientific journals, reflecting her impact on global microbiology and pharmaceutical sciences.

🔬 Research Focus

Dr. Basu’s research interests revolve around biofilm formation, antibiotic resistance mechanisms, and innovative drug therapies. Her work has significantly contributed to understanding Pseudomonas aeruginosa biofilms, Vibrio gazogenes interactions, and novel antibiotic treatments. Additionally, she explores the role of multimedia learning tools in medical education, aiming to improve student engagement and knowledge retention in pharmaceutical sciences.

🔎 Conclusion

Dr. Paramita Basu is a renowned microbiologist, educator, and researcher with a passion for antimicrobial resistance and innovative learning in pharmaceutical sciences. Her groundbreaking work in infectious disease research and medical education has solidified her position as a leader in the field. With a commitment to scientific advancement and student success, she continues to make a significant impact in pharmaceutical and biomedical sciences. 🚀

📚 Publications

Development and Control of Biofilms in Diabetic Foot Infections: A Narrative Review Acta Microbiologica Hellenica (2025) [🔗DOI: 10.3390/amh70010009]

Integration of an Audiovisual Learning Resource in a Podiatric Medical Infectious Disease Course: Multiple Cohort Pilot Study – JMIR Medical Education (2025) [🔗DOI: 10.2196/55206]

Study of the impact of introducing a multimedia learning tool in podiatric medical courses – Journal of Foot and Ankle Research (2024) [🔗DOI: 10.1002/jfa2.12018]

Antibiotic-Induced Changes in Efflux Transporter Expression: A Key Factor in Pseudomonas aeruginosa Biofilm Resistance – Journal of Experimental Biology and Agricultural Sciences (2024) [🔗DOI: 10.18006/2024.12(2).274.283]

Vibrio gazogenes-dependent disruption of aflatoxin biosynthesis in Aspergillus flavus – Frontiers in Microbiology (2023) [🔗DOI: 10.3389/fmicb.2023.1208961]

The Effect of Antibiotic Treatment and Gene Expression of Mex B Efflux Transporters on the Resistance in Pseudomonas Aeruginosa Biofilms Applied Microbiology (2023) [🔗DOI: 10.3390/applmicrobiol3030049]

Surveillance of SARS-CoV-2 RNA in open-water sewage canals – Access Microbiology (2022) [🔗DOI: 10.1099/acmi.0.000318]

Antimicrobial Resistance in Pseudomonas aeruginosa Biofilms – Journal of Pure and Applied Microbiology (2021) [🔗DOI: 10.22207/JPAM.15.4.79]